Leishmaniasis, Cutaneous: Clinical Trials

28 trials for Leishmaniasis, Cutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 6 unknown, 4 terminated, 2 not yet recruiting. 28 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 328Completed 15, Unknown 6, Terminated 4, Not yet recruiting 2, Recruiting 1
Phase 29Completed 5, Unknown 3, Terminated 1

Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)
Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium9002027-01-012026-03-10
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
Arnica Tincture, Meglumine antimoniate. - Leishmaniasis, Cutaneous
Phase 3RecruitingUniversidad de Antioquia962026-03-112026-04-02
Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia
Fusidic Acid, Vehicle cream - Leishmaniasis, Cutaneous
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium1802025-04-012024-11-19
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3UnknownHospital Universitário Professor Edgard Santos222023-10-012023-08-25
Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
drug: miltefosine with thermotherapy - Old World Cutaneous Leishmaniasis
Phase 3CompletedMedecins Sans Frontieres, Netherlands6452022-10-072026-07-30
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous
Phase 2 / Phase 3UnknownUniversity of Brasilia1002022-06-222023-09-15
Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional Voriconazole - Leishmaniasis, Cutaneous
Phase 3UnknownZagazig University1362022-01-012023-08-29
Treatment of Mucosal Bolivian Leishmaniasis
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B - Mucosal Leishmaniasis
Phase 3UnknownFundacion Nacional de Dermatologia1202021-04-012024-03-05
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
Spatial repellant emanator - Leishmaniasis, Cutaneous, Vector Borne Diseases
Phase 3CompletedThe Mentor Initiative184042021-02-012025-04-08
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
Meglumine Antimoniate, Miltefosine, Thermotherapy machine - Cutaneous Leishmaniases
Phase 3CompletedDrugs for Neglected Diseases1842021-01-262025-05-08
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
Miltefosine and Paromomycin, miltefosine, paromomycin - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3CompletedFundacion Nacional de Dermatologia1202019-02-012021-02-02
Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
HECT-CL - Cutaneous Leishmaniases
Phase 3TerminatedMedecins Sans Frontieres, Netherlands562017-10-042019-01-16
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Sbv, Miltefosine plus placebo, Miltefosine plus GM-CSF - Cutaneous Leishmaniasis
Phase 3CompletedHospital Universitário Professor Edgard Santos3002017-06-302020-04-07
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
Paromomycin Sulfate, Pentamidine Isethionate, Placebo - Leishmaniasis, Cutaneous, Leishmania Braziliensis Complex
Phase 2 / Phase 3CompletedFundacion Nacional de Dermatologia802017-04-152021-02-02
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Fluconazole, Meglumine Antimoniate - Cutaneous Leishmaniasis
Phase 3TerminatedHospital Universitário Professor Edgard Santos532014-02-012015-12-02
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
WR 279,396, Paromomycin - Cutaneous Leishmaniasis
Phase 3CompletedU.S. Army Medical Research and Development Command3992013-05-012018-02-14
Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Pentoxifylline, Placebo - Cutaneous Leishmaniasis
Phase 2 / Phase 3CompletedPaulo Roberto Lima Machado1642012-03-012017-01-26
Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Meglumine antimonate, Placebo, Pentoxifylline - Cutaneous Leishmaniasis
Phase 2 / Phase 3CompletedCentro Internacional de Entrenamiento e Investigaciones Médicas752011-11-012016-08-23
Low Antimonial Dosage in American Mucosal Leishmaniasis
Meglumine antimoniate - Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis
Phase 2 / Phase 3UnknownOswaldo Cruz Foundation762008-10-012018-07-12
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
Meglumine antimoniate - Cutaneous Leishmaniasis
Phase 2 / Phase 3CompletedOswaldo Cruz Foundation722008-10-012018-05-15

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Leishmaniasis (6)  ·  Leishmaniasis, Mucocutaneous (6)  ·  Hyperthermia (3)  ·  Vector Borne Diseases (1)

Broader conditions

Euglenozoa Infections (28)  ·  Infections (28)  ·  Parasitic Diseases (28)  ·  Protozoan Infections (28)  ·  Skin Diseases (28)  ·  Skin Diseases, Infectious (28)  ·  Skin Diseases, Parasitic (28)  ·  Skin and Connective Tissue Diseases (28)  ·  Vector Borne Diseases (27)  ·  Leishmaniasis (22)  ·  Body Temperature Changes (3)  ·  Heat Stress Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)

Interventions

Meglumine Antimoniate (12)  ·  miltefosine (8)  ·  Paromomycin (4)  ·  Pentoxifylline (3)  ·  Hyperthermia, Induced (2)  ·  Pentamidine (2)  ·  liposomal amphotericin B (2)  ·  Antimony Sodium Gluconate (1)  ·  Arnicae flos extract (1)  ·  Azithromycin (1)  ·  Contraceptives, Oral (1)  ·  Doxycycline (1)  ·  Fluconazole (1)  ·  Fusidic Acid (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)

Sponsors

Fundacion Nacional de Dermatologia (3)  ·  Hospital Universitário Professor Edgard Santos (3)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (2)  ·  Drugs for Neglected Diseases (2)  ·  Institute of Tropical Medicine, Belgium (2)  ·  Medecins Sans Frontieres, Netherlands (2)  ·  Oswaldo Cruz Foundation (2)  ·  Tehran University of Medical Sciences (2)  ·  U.S. Army Medical Research and Development Command (2)  ·  Universidad de Antioquia (2)  ·  Ana Rabello (1)  ·  Fundación Cardiovascular de Colombia (1)  ·  Paulo Roberto Lima Machado (1)  ·  The Mentor Initiative (1)  ·  University of Brasilia (1)

Countries

Brazil (9)  ·  Bolivia (4)  ·  Colombia (4)  ·  Ethiopia (2)  ·  Iran (2)  ·  Pakistan (2)  ·  Panama (2)  ·  Peru (2)  ·  Libya (1)  ·  Syria (1)  ·  Tunisia (1)

Top investigators

Armando O. Schubach, MD, PhD (2)  ·  Afif Ben Salah, M.D., Ph.D. (1)  ·  Ali Khamesipour (1)  ·  Ali Khamesipour, PhD (1)  ·  Alireza Khatami, MD MSPH (1)  ·  Ana Rabello, MD PhD (1)  ·  Catherine Royce, Dr (1)  ·  Christian F Rueda-Clausen, MD (1)  ·  Daniel J Smith, PhD (1)  ·  Daniel Smith, PhD (1)  ·  Edgar M Carvalho, MD, PhD (1)  ·  Federico A Silva, MD (1)  ·  Fiorela Yuly Alvarez Romero (1)

Results publications

PMID 28379954, PMID 19636365, PMID 22238470, PMID 22594858, PMID 23388004, PMID 23740007, PMID 27803094, PMID 28558061, PMID 30260376, PMID 32894278, PMID 33253864, PMID 40611204